Renin-angiotensin system inhibitors and COVID-19: Potential therapeutics rather than perpetrators
Journal
Acta Cardiologica Sinica
Journal Volume
36
Journal Issue
3
Pages
179-182
Date Issued
2020
Author(s)
SDGs
Other Subjects
amino terminal pro brain natriuretic peptide; angiotensin 1 receptor; angiotensin converting enzyme 2; angiotensin II; angiotensin receptor antagonist; angiotensin[1-7]; apelin; camostat mesilate; dipeptidyl carboxypeptidase inhibitor; enkephalinase inhibitor; membrane protein; transmembrane protease serine 2; tumor necrosis factor alpha converting enzyme; unclassified drug; virus spike protein; acute lung injury; cardiovascular risk; cerebrovascular disease; coronary artery disease; coronavirus disease 2019; diabetes mellitus; Editorial; heart left ventricle ejection fraction; human; hypertension; mortality; nonhuman; prevalence; protein degradation; protein expression; renin angiotensin aldosterone system; risk factor; SARS coronavirus; Severe acute respiratory syndrome coronavirus 2; virus entry; virus shedding
Publisher
Republic of China Society of Cardiology
Type
editorial